Patent

Click here to view our Patent professionals

MBHB has experience on both sides of the patent - we are accomplished patent agents and deftly manage the patent prosecution process, while we also provide aggressive, goal-focused counsel in patent litigation matters.

Our attorneys have broad patent litigation experience, both enforcing patents and defending against infringement allegations. Our patent attorneys and patent agents are also highly adept in all aspects of patent procurement, including drafting applications and prosecuting them before the U.S. Patent and Trademark Office as well as in other countries. MBHB prosecutes interferences in the U.S. Patent and Trademark Office and assists in foreign patent oppositions. We negotiate patent licenses and help our clients establish and manage patent portfolios worldwide.

P: 312.913.2141
F: 312.913.0002
P: 312.913.3342
F: 312.913.0002
P: 312.913.2104
F: 312.913.0002
P: 312.935.2369
F: 312.913.0002
P: 312.913.2140
F: 312.913.0002
Senior Patent Agent
P: 312.913.3357
F: 312.913.0002
P: 312.913.2130
F: 312.913.0002
P: 312.913.3361
F: 312.913.0002
P: 312.913.2146
F: 312.913.0002
P: 312.913.3381
F: 312.913.0002
P: 312.913.2144
F: 312.913.0002
P: 312.913.3330
F: 312.913.0002
P: 312.913.2131
F: 312.913.0002
P: 312.913.3345
F: 312.913.0002
P: 312.913.3313
F: 312.913.0002
Associate
P: 312.913.3305
F: 312.913.0002
P: 312.913.3341
F: 312.913.0002
P: 312.913.3397
F: 312.913.0002
P: 312.913.2109
F: 312.913.0002
P: 312.913.2121
F: 312.913.0002
P: 360.379.6514
F: 312.913.2557
P: 312.913.2117
F: 312.913.0002
P: 312.913.3369
F: 312.913.0002
P: 312.913.2143
F: 312.913.0002
P: 312.913.3315
F: 312.913.0002
P: 312.913.3334
F: 312.913.0002
P: 312.913.2139
F: 312.913.0002
P: 312.913.3333
F: 312.913.0002
P: 312.913.3392
F: 312.913.0002
P: 312.913.3360
F: 312.913.0002
P: 312.913.3353
F: 312.913.0002
P: 312.913.2135
F: 312.913.0002
P: 312.913.3366
F: 312.913.0002
P: 312.913.2116
F: 312.913.0002
P: 312.913.2106
F: 312.913.0002
P: 312.913.3331
F: 312.913.0002
P: 312.935.2371
F: 312.913.0002
Patent Agent
P: 312.913.3319
F: 312.913.0002
P: 312.913.2123
F: 312.913.0002
P: 312.913.2122
F: 312.913.0002
P: 312.913.2137
F: 312.913.0002
P: 312.935.2372
F: 312.913.0002
P: 312.935.2355
F: 312.913.0002
P: 312.913.3304
F: 312.913.0002
Patent Agent
P: 312.913.3380
F: 312.913.0002
P: 312.913.3398
F: 312.913.0002
Associate
P: 312.913.2125
F: 312.913.0002
P: 312.913.3311
F: 312.913.0002
P: 312.913.3393
F: 312.913.0002
P: 312.913.3346
F: 312.913.0002
P: 312.913.3338
F: 312.913.0002
P: 312.913.2112
F: 312.913.0002
P: 312.913.2129
F: 312.913.0002
Patent Agent
P: 312.913.3358
F: 312.913.0002
P: 312.935.2359
F: 312.913.0002
Patent Agent
P: 312.913.2357
F: 312.913.0002
P: 312.913.3344
F: 312.913.0002
P: 312.913.2126
F: 312.913.0002
P: 312.913.3350
F: 312.913.0002
P: 312.913.3302
F: 312.913.0002
P: 312.935.2370
F: 312.913.0002
P: 312.913.2145
F: 312.913.0002
P: 312.913.3396
F: 312.913.0002
Technical Advisor
P: 312.913.3394
F: 312.913.0002
P: 312.913.2147
F: 312.913.0002
P: 312.913.3335
F: 312.913.0002
P: 312.913.3349
F: 312.913.0002
Associate
P: 312.913.2118
F: 312.913.0002
P: 312.935.2366
F: 312.913.0002
P: 312.913.3303
F: 312.913.0002
P: 312.913.3376
F: 312.913.0002
P: 312.913.3347
F: 312.913.0002
P: 312.913.3399
F: 312.913.0002
P: 312.913.2133
F: 312.913.0002
P: 312.913.3351
F: 312.913.0002
P: 312.913.3356
F: 312.913.0002
P: 312.913.2119
F: 312.913.0002
P: 312.913.2136
F: 312.913.0002
P: 312.935.2353
F: 312.913.0002
P: 312.913.3391
F: 312.913.0002
P: 312.913.3337
F: 312.913.0002
P: 312.913.3359
F: 312.913.0002
P: 312.913.0001
F: 312.913.0002
P: 312.913.3367
F: 312.913.0002
P: 312.913.3348
F: 312.913.0002
P: 312.935.2356
F: 312.913.0002
P: 312.913.3329
F: 312.913.0002
P: 312.913.3300
F: 312.913.0002
P: 312.935.2379
F: 312.913.0002
P: 312.913.2128
F: 312.913.0002
P: 312.913.3368
F: 312.913.0002
P: 312.913.2138
F: 312.913.0002
P: 312.913.3301
F: 312.913.0002
P: 312.913.2114
F: 312.913.0002
Partner
P: 312.913.3390
F: 312.913.0002
Associate
P: 312.913.2142
F: 312.913.0002
P: 312.913.2132
F: 312.913.0002

Upcoming Events

September 11-12, 2014
Five MBHB Partners Are Featured Presenters at this PLI-Sponsored Seminar
October 2, 2014
MBHB Partners Kevin Noonan, Ph.D. and Donald Zuhn, Jr., Ph.D. Are the Featured Co-Presenters
October 20, 2014
MBHB Partner Lisa Schoedel Is the Featured Presenter at this IEEE-Sponsored Program

Past Event

August 19, 2014
MBHB Attorneys Rory Shea and Michael Borella, Ph.D. Are the Featured Co-Presenters
July 9, 2014
MBHB Partners Grantland Drutchas and Donald Zuhn, Ph.D. Are the Featured Co-Presenters
July 2, 2014
MBHB Partners Lawrence Aaronson, Michael Borella and Grantland Drutchas Are Featured Presenters at this PLI-Sponsored Webinar
June 26, 2014
MBHB Partner Kurt Rohde Is a Featured Presenter
June 25, 2014
MBHB Partner Dr. Donald Zuhn is the Featured Moderator at this BIO 2014 Session

Publications

Summer 2014 (snippets)
The CLS Bank case is the most recent of the Court’s patent eligibility decisions, and the Court unanimously affirmed the Federal Circuit's per curiam opinion (itself an effort to apply the Court’s patent eligibility jurisprudence regarding computer-based methods) that all of Alice’s claims were too abstract to meet the requirements of § 101. The claims at issue included method claims (directed, according to the Court, to methods for implementing an intermediated settlement that are well-known in the art), system claims involving implementation of the method using a general purpose computer, and computer readable-media claims for directing a general purpose computer to implement the method. None of the distinctions thought heretofore to matter between claims to methods, systems, and computer-readable media made any difference to the Court.
Summer 2014 (snippets)
In the seminal decision of Egyptian Goddess, Inc. v. Swisa, Inc., the Federal Circuit struck down one of the two tests commonly used for determining design patent infringement, the “point of novelty” test. Despite rejecting this test, the court incorporated the consideration of prior art into a slightly revised version of the "ordinary observer" test, the hypothetical "ordinary observer" now having familiarity with the prior art. This article will examine the application of this revised version of the "ordinary observer" test, and specifically the consideration of the “plainly dissimilar” analysis set forth by Egyptian Goddess.
June 19, 2014 (snippets Alert)
MBHB snippets Alert - June 19, 2014

In the U.S. Supreme Court’s decision today in Alice Corp. v. CLS Bank International, the Court affirmed the invalidity of Alice’s patents for computer-implemented methods of reducing settlement risk. This case reached the high court after a severely split Federal Circuit could not agree whether language of the claims met the patent-eligibility requirements of 35 U.S.C. § 101. At the heart of this case was the Federal Circuit’s confusion over the impact of the Court’s 2012 decision, Mayo Collaborative Services v. Prometheus Laboratories, Inc.

June 2, 2014 (snippets Alert)
MBHB snippets Alert - June 2, 2014

In the U.S. Supreme Court’s decision today in Limelight Networks, Inc. v. Akamai Technologies, Inc., the Supreme Court reversed the Federal Circuit's en banc holding that a defendant need not perform all of the steps of a claim to infringe where it performs some and induces third parties to perform the rest.
June 2, 2014 (snippets Alert)
MBHB snippets Alert - June 2, 2014

In today’s decision, the U.S. Supreme Court in Nautilus, Inc. v. Biosig Instruments, Inc. clarified the scope of definiteness required to fulfill the requirement that the patent claims particularly point out and distinctly claim the subject matter which the applicant regards as the invention. In Nautilus, the U.S. Supreme Court unanimously rejected the “insolubly ambiguous” standard previously set out by the Federal Circuit.
Spring 2014 (snippets)
The past year has been unusually active for the “first sale” doctrine. Also known as patent exhaustion, the doctrine is based upon the premise that a patent holder is entitled to only one royalty for its sale of a patented article. Therefore, once the patent holder has received consideration for an unconditional sale of a patented article, the holder “surrenders all rights to any future use or sale of it.” The underlying rationale is that the consideration bargained for as part of the sale represents the benefit that the patent laws were meant to bestow on the patent holder.
Close
Generate a PDF of your page(s)
Clear
Close
Remove
Page has been queued
An error has occurred
Add
Added to queue
View
Confirm Delete All Message
No Items in Packet Message
To add a page, select Add. To view the package, select View.
false
http://www.mbhb.com/services/xpqServiceDetail.aspx?xpST=ServiceDetail&service=289&pdf=yes
a[href='javascript:packetBuilderSingleClick(document.title);']